NTAP
64
-2
AME
63
3
SCHW
52
3
MSFT
65
-2
KR
40
-10
HIG
74
2
AFL
64
2
FITB
50
2
UAL
38
4
AIG
53
2
KLAC
61
-4
EQT
25
6
DGX
33
2
BEN
48
4
AMGN
57
11
ROP
74
2
EQR
67
2
VZ
29
5
MLM
61
-2
NTRS
44
5
NTAP
64
-2
AME
63
3
SCHW
52
3
MSFT
65
-2
KR
40
-10
HIG
74
2
AFL
64
2
FITB
50
2
UAL
38
4
AIG
53
2
KLAC
61
-4
EQT
25
6
DGX
33
2
BEN
48
4
AMGN
57
11
ROP
74
2
EQR
67
2
VZ
29
5
MLM
61
-2
NTRS
44
5
Financhill
Back

ITeos Therapeutics Vs. Ultragenyx Pharmaceutical Industry Stock Comparison

Buy
60

ITOS
ITeos Therapeutics

Last Price:
14.65
Seasonality Move:
-5.35%
Sell
43

RARE
Ultragenyx Pharmaceutical

Last Price:
39.82
Seasonality Move:
-0.9%
Buy
60
ITeos Therapeutics (ITOS) is a Buy

Is ITeos Therapeutics a Buy, Sell or Hold?

  • The current ITeos Therapeutics [ITOS] share price is $14.89. The Score for ITOS is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
  • ITOS is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
43
Ultragenyx Pharmaceutical (RARE) is a Sell

Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?

  • The current Ultragenyx Pharmaceutical [RARE] share price is $39.39. The Score for RARE is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
  • RARE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

ITOS Stock Price Chart

What is ITeos Therapeutics's stock price today?

  • The ITeos Therapeutics share price today is $14.89
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ITOS is experiencing slight buying pressure.

RARE Stock Price Chart

What is Ultragenyx Pharmaceutical's stock price today?

  • The Ultragenyx Pharmaceutical share price today is $39.39
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RARE is experiencing selling pressure, which indicates risk of future bearish movement.

ITOS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.11 Sell
Relative Strength Index (14 RSI): 39.83 Sell
Chaikin Money Flow: 136251 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (15.65 - 17.69) Sell
Bollinger Bands (100): (10.21 - 15.63) Buy

RARE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.74 Sell
Relative Strength Index (14 RSI): 45.16 Sell
Chaikin Money Flow: -377368 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (38.89 - 42.13) Sell
Bollinger Bands (100): (40.93 - 48.81) Sell

ITOS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 15.46 Sell
20-day SMA: 16.36 Sell
50-day SMA: 14.59 Buy
200-day SMA: 11.68 Buy
8-day EMA: 15.36 Sell
20-day EMA: 15.82 Sell
50-day EMA: 14.97 Sell
200-day EMA: 13.14 Buy

RARE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 40.13 Sell
20-day SMA: 40.38 Sell
50-day SMA: 41.72 Sell
200-day SMA: 42.46 Sell
8-day EMA: 39.68 Sell
20-day EMA: 40.43 Sell
50-day EMA: 41.92 Sell
200-day EMA: 43.42 Sell

ITeos Therapeutics Earnings Growth & ITOS Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.23 per share, a decrease next quarter of $0.85 per share, a decrease this year of $0.78 per share, and a decrease next year of $0.91 per share.

Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.49 per share, an increase next quarter of $0.01 per share, an increase this year of $0.90 per share, and an increase next year of $1.07 per share.

ITeos Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Ultragenyx Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):